PsychCombo: Communicating drug combinations
PsychCombo is a website listing psychoactives in a dynamic combination display, allowing users to select their own combinations. PsychCombo’s risk ratings include citations used to calculate the risk rating, and a confidence rating for the risk rating itself.
Global Drug Survey 2024 - we need your help!
The Global Drug Survey is the world’s largest survey of drug use. Its aim is to ensure that the voices of those who use drugs are heard and considered in government decision-making processes, and to make drug use safer for individuals, regardless of the legal status of the substances involved.
The pros and cons of asking chatbots about drugs
Go ahead: ask a chatbot a drug-related question, and if in doubt, throw the results to the Bluelight community and see if they agree. And if you get conflicting answers, it might be time to call on a recognised expert.
Yes, dealers are on socials, but what about your friends?
Social media and messaging apps increasingly serve as sources of drug access, especially among younger age groups.
REMINDER - Stay Within The Law & The BLUA When Using Bluelight
Opioids were the most common substances contributing to fatal poisonings among young children.
Workers Fighting America’s Overdose Crisis Are ‘Hanging by a Thread’
Colorado becomes second state to legalize “magic mushrooms”
Chronic pain sufferers and the ever-changing laws
PsychCombo: Communicating drug combinations
by Dr Liam Engel
The pros and cons of asking chatbots about drugs
by Stu Hatton
Yes, dealers are on socials, but what about your friends?
by Robin van der Sanden, PhD
Harm Reduction Centered
Bluelight has a 20 year legacy of supporting people who use drugs. Our forums and digital channels focus on reducing harm and protecting our community.
No Judgement
We provide a peer-to-peer platform for people who use drugs to communicate freely, without judgement. We are inclusive and accepting, acknowledging that everyone’s experiences are different.
Research for Results
Our research partnerships are pivotal to reducing harm by connecting people who use drugs with researchers, empowering them to share their experiences and advocate for themselves.
Join the Bluelight community
Bluelight is entirely member led, ensuring that focus never strays from the altruistic foundation that is about nurturing open and supportive communities among members from right across the globe.
Contributors
Monica Barratt
Executive Director
Dr Monica Barratt is the Executive Director of Bluelight.org and has over 20 years’ experience working in drug research. She is passionate about engaging the drug-using community as active participants in the research and policy space.
Stu Hatton
Managing Editor
Stu is a writer, editor, and educator. He is managing editor of the Bluelight website.
Liam Engel
Contributor
Dr Liam Engel is an ethnobotanist and science communicator. He is creator of The Mescaline Garden educational nursery, producer for the ethnobotanical charity Entheogenesis Australis, natural products chemist at NICM Health Research Institute and author of Thames and Hudson’s forthcoming psychoactive plant compendium.
Robin van der Sanden
Contributor
Robin completed a PhD in Public health with SHORE & Whāriki Research Centre, Massey University in 2023. Her research explores intersections between social media, drug use and drug trading.
Adam Susel
Contributor
Adam is a recent graduate of West Virginia University, where he studied mathematics. His academic interests include neuroscience, applied math, statistics, and public health.
Truly Community Led
Unlike other med-based forums, Bluelight is entirely member led, ensuring that focus never strays from the altruistic foundation that is about nurturing open and supportive communities amongst members from right across the globe.